Cell Harvesting Systems Market

Cell Harvesting Systems Market Overview

The cell harvesting systems market is likely to upscale from USD 6.3 billion in 2022 to USD 19.1 billion by 2032. Demand is likely to rise at a significant CAGR of 12.6% during the forecast period.

The demand for cell harvesting and bone marrow transplantation therapy is projected to increase as the prevalence of blood illnesses, such as blood cancer, rises. Additionally, 174,250 people in the United States are anticipated to receive a lymphoma, leukemia, or myeloma diagnosis in 2018, according to a study done by the Leukemia & Lymphoma Society.

The market is benefited from the growing understanding of the advantages of stem cells and how they might be used to treat diseases.

However, during the forecast period, the market expansion is anticipated to be constrained by ethical concerns surrounding embryonic stem cells and unlicensed stem cell therapy offered by healthcare providers in uncontrolled regions like Latin America and Asia Pacific.

Moreover, the cell harvesting systems market is very competitive, with several companies selling comparable goods. Companies may find it challenging to differentiate themselves and obtain a competitive edge as a result.

“The accelerating trend of transplantation and the increasing need for stem cell banking are further factors contributing to the expansion of the cell harvesting systems market.”

The process of separating the cells from the substance in which they are multiplied by filtering or centrifugation method and extracting the desired cells from the growth medium is known as cell harvesting. A powerful and controlled system called a cell harvesting system is used to extract live cells from bioreactors. To be a closed system, it is ideal for collecting seed cells for increasing without needing to be concerned about contamination.

Attributes	Details
Cell harvesting systems market CAGR (2022 to 2032)	12.6%
Cell harvesting systems market Size 2022	USD 6.3 billion
Cell harvesting systems market Size 2032	USD 19.1 billion

Potential Investment in Cell-based Science leads to Profitable Breakthroughs

• The cell harvesting systems market is growing as a result of expanding biotechnology and pharmaceutical industries, as well as rising investment in regenerative medicine and cell-based research.
• To develop regenerative medicines, many businesses are concentrating on adult stem cell transplants and cardiac tissue regeneration. The adoption of cell harvesting is expected to grow during the forecast period as a result of a number of technological developments that support new and improved technologies with improved performance.
• Prospects for the market growth include increasing investment in logistical infrastructure, expanding the bone marrow transplant registry for neurological and cardiac conditions, and increasing per capita healthcare spending.
• Businesses are creating automated harvesting and cryopreservation technologies that can boost productivity and lower costs. The development of technologies that can be utilized to safely and effectively harvest, process, and store stem cells is also receiving more attention.
• Governments and other regulatory authorities globally are creating rules and regulations to guarantee the secure and efficient use of stem cell collection and storage.
• During the forecast period, these restrictions are anticipated to fuel the cell harvesting industry. Additionally, the cell harvesting systems market share is anticipated to grow as a result of the increasing emphasis on research and development activities.

What are the Major Drivers Boosting the Demand for the Cell Harvesting Systems Market?

The major drivers of market expansion for cell harvesting systems are rising investments in regenerative medicine and cell-based research, expanding biotechnology and biopharmaceutical sectors, and rising prevalence of infectious and chronic diseases.

Due to urbanization, sedentary lifestyles, changing diets, rising obesity rates, and widespread access to tobacco products, cancer, and heart disease are now the leading causes of death in developing economies. The primary driver of market expansion is the potential application of stem cells in the treatment of numerous chronic diseases. Therefore, it is anticipated that the incidence of chronic and infectious disorders will drive the cell harvesting systems market expansion.

The market for cell harvesting systems is anticipated to grow significantly as bone marrow transplant procedures become more prevalent due to rising rates of anemia and blood cancer. In addition, increased healthcare spending per capita, post-therapy survival, logistical facility investment, expansion of the cardiac bone marrow transplant registry, and neurological ailments are all important factors.

Which Region Shows Strong Growth Potential in the Cell Harvesting Systems Market?

The cell harvesting systems market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

North America is the leading region in the global cell harvesting systems market due to increased study spending and public projects, frequent use of stem cells for the treatment of cancer patients, and increased healthcare spending.

Apart from North America, the European cell harvesting systems market is also expected to display lucrative growth in the projected years due growing geriatric population and the presence of major players in the industry.

The East Asian region is predicted to show lucrative growth owing to the growing rates of cardiovascular diseases coupled with the rising geriatric population.

Who are the Key Players in the Cell Harvesting Systems Market?

Sartorius AG, Danaher Corporation, Cox Scientific Ltd., Thomas Scientific, Teleflex Inc, Argos Technologies Inc, Perkin Elmer Inc, Arthrex Inc., Avita Medical, Tomtec, erumo Corporation, and Bertin.

Scope of Report

Report Attributes	Details
Growth Rate	CAGR of 12.6% 2022 to 2032
Base Year for Estimation	2021
Historical Data	2012 to 2021
Forecast Period	2022 to 2032
Qualitative Units	Revenue in USD Billion, Volume in Units, and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segment Covered	Technology, Application, End User, Region
Region Covered	North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa
Key Countries Profiled	USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel
Key Players	Sartorius AG; Danaher Corporation; Cox Scientific Ltd.; Thomas Scientific; Teleflex Inc; Argos Technologies Inc; Perkin Elmer Inc; Arthrex Inc.; Avita Medical; Tomtec; Terumo Corporation; Bertin
Customization	Available Upon Request

Table of Content

• 1. Executive Summary
• 2. Industry Introduction, including Taxonomy and Market Definition
• 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
• 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
• 5. Pricing Analysis
• 6. Global Market Analysis and Forecast
  • 6.1. Technology
  • 6.2. Application
  • 6.3. End User
• 7. Global Market Analysis and Forecast, By Technology
  • 7.1. Blastomere Extraction
  • 7.2. Altered Nuclear Transfer
• 8. Global Market Analysis and Forecast, By Application
  • 8.1. Bone Marrow
  • 8.2. Umbilical Cord
  • 8.3. Adipose Tissue
  • 8.4. Peripheral Blood
• 9. Global Market Analysis and Forecast, By End User
  • 9.1. Research Centers
  • 9.2. Biotechnology and Biopharmaceutical Companies
  • 9.3. Diagnostic Labs
  • 9.4. Others
• 10. Global Market Analysis and Forecast, By Region
  • 10.1. North America
  • 10.2. Latin America
  • 10.3. Europe
  • 10.4. East Asia
  • 10.5. South Asia
  • 10.6. Oceania
  • 10.7. The Middle East and Africa (MEA)
• 11. North America Sales Analysis and Forecast, by Key Segments and Countries
• 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries
• 13. Europe Sales Analysis and Forecast, by Key Segments and Countries
• 14. East Asia Sales Analysis and Forecast, by Key Segments and Countries
• 15. South Asia Sales Analysis and Forecast, by Key Segments and Countries
• 16. Oceania Sales Analysis and Forecast, by Key Segments and Countries
• 17. The Middle East and Africa (MEA) Sales Analysis and Forecast, by Key Segments and Countries
• 18. Sales Forecast by Technology, Application, and End User for 30 Countries
• 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
• 20. Company Profile
  • 20.1. Sartorius AG
  • 20.2. Danaher Corporation
  • 20.3. Cox Scientific Ltd.
  • 20.4. Thomas Scientific
  • 20.5. Teleflex Inc
  • 20.6. Argos Technologies Inc
  • 20.7. Perkin Elmer Inc
  • 20.8. Arthrex Inc.
  • 20.9. Avita Medical
  • 20.10. Tomtec
  • 20.11. Terumo Corporation
  • 20.12. Bertin